In the follow-up of DTC, the greatest challenge is patients with serum Tg–IMA concentrations suggesting tumour absence in whom it is not possible to ensure whether this finding indicates complete remission or underestimated Tg due to the interference of TgAb (6). The gene discussed is TG; the disease is neoplasm.